<DOC>
	<DOCNO>NCT02556892</DOCNO>
	<brief_summary>The purpose study evaluate safety Ibrutinib Japanese participant treatment-naive chronic lymphocytic leukemia ( CLL ) small lymphocytic lymphoma ( SLL ) .</brief_summary>
	<brief_title>A Study Bruton 's Tyrosine Kinase ( BTK ) Inhibitor Ibrutinib Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma</brief_title>
	<detailed_description>This Phase 1 , open-label multicenter study . The study consist Screening Phase ( 28 day prior first administration study drug ) , Treatment Phase ( time first dose ibrutinib administer disease progression , investigator long considers treatment tolerable , participant meet one discontinuation criterion ) Follow-up Phase ( end last dose study drug 30 day last dose study drug start subsequent anti-CLL/SLL therapy , whichever come first ) . Participants instruct take 3 capsule ibrutinib ( dose 420 mg ) orally daily start Cycle 1 , Day 1 . Participants ' safety monitor throughout study .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<criteria>Diagnosis lymphocytic leukemia ( CLL ) small lymphocytic lymphoma ( SLL ) meet publish diagnostic criterion For CLL participant : Measurable nodal disease compute tomography ( CT ) , define least 1 lymph node great ( &gt; ) 1.5 centimeter ( cm ) long diameter site previously irradiate . Adequate hepatic function , define serum aspartate transaminase ( AST ) alanine ; For SLL participant : At least 1 measurable site disease accord Revised Response Criteria Malignant Lymphoma Eastern Cooperative Oncology Group ( ECOG ) performance status 01 Adequate hepatic function , define serum aspartate transaminase ( AST ) alanine transaminase ( ALT ) &lt; 2.5 × upper limit normal ( ULN ) , total bilirubin less equal ( &lt; = ) 1.5 × ULN ( unless due Gilbert 's syndrome ) A woman childbearing potential must negative serum ( betahuman chorionic gonadotropin [ betahCG ] ) urine pregnancy test screen Known involvement central nervous system lymphoma leukemia History current evidence Richter 's transformation prolymphocytic leukemia Uncontrolled autoimmune hemolytic anemia idiopathic thrombocytopenic purpura Any previous treatment ( chemotherapy , radiotherapy , and/or monoclonal antibody ) intend specifically treat CLL/SLL Received immunotherapy , live vaccine , investigational drug within 4 week prior first dose study drug</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Lymphocytic Leukemia</keyword>
	<keyword>Ibrutinib</keyword>
	<keyword>PCI-32765</keyword>
	<keyword>JNJ-54179060</keyword>
</DOC>